Hyperglycemia has, therefore, a prominent role in the onset of hyperfiltration, while SGLT2-inhibitors have become important therapeutic tools to prevent progression towards CKD in diabetic individuals [1,21,22,23]. The gene discussed is SLC5A2; the disease is chronic kidney disease.